Recent from talks
Marcia Angell
Knowledge base stats:
Talk channels stats:
Members stats:
Marcia Angell
Marcia Angell (/ˈeɪndʒəl/; born April 20, 1939) is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine. She is currently a Corresponding Member of the Faculty of Global Health and Social Medicine at Harvard Medical School in Boston, Massachusetts.
After completing undergraduate studies in chemistry and mathematics at James Madison University in Harrisonburg, Virginia, Angell spent a year as a Fulbright Scholar studying microbiology in Frankfurt, Germany. After receiving her M.D. from Boston University School of Medicine in 1967, Angell trained in both internal medicine and anatomic pathology and is a board-certified pathologist.
Angell is a frequent contributor to medical journals as well as in the popular media, where she has offered her perspective on topics including medical ethics, health policy, psychiatry, the opioid epidemic, the nature of medical evidence, the interface of medicine and the law, and end-of-life healthcare. Her book, Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case (1996), received critical acclaim. With Stanley Robbins, and later with Vinay Kumar, she co-authored the first three editions of the textbook Basic Pathology. She has written chapters in several books dealing with ethical issues in medicine and healthcare.
Angell is a member of the Association of American Physicians, the Institute of Medicine of the National Academy of Sciences, the Alpha Omega Alpha National Honor Medical Society, and is a Master of the American College of Physicians. She is also a fellow of the Committee for the Scientific Investigation of Claims of the Paranormal and is an outspoken critic of medical quackery and the promotion of alternative medicine.
Angell joined the editorial staff of The New England Journal of Medicine (NEJM) in 1979. She became Executive Editor in 1988, and served as interim Editor-in-Chief from 1999 until June 2000. The NEJM is the oldest continuously published medical journal, and one of the most prestigious; Angell is the first woman to have served as Editor-in-Chief of the journal since it was founded in 1812.
In 1999, Jerome P. Kassirer, M.D. resigned as NEJM's Editor-in-Chief following a dispute with the journal's publisher, the Massachusetts Medical Society, over its plan to use the journal's name to brand and market other sources of healthcare information. Angell agreed to serve as interim Editor-in-Chief until a permanent editor was chosen. She reached an agreement with the Society that the Editor-in-Chief would have authority over usage of the journal's name and logo, and that the journal's name would not be used on other products. She was a finalist for the permanent post of Editor-in-Chief, but withdrew as a candidate explaining that she was retiring to write a book on alternative medicine. Angell retired from the journal in June 2000 and was replaced by Jeffrey Drazen, M.D.
In her 2009 article "Drug Companies & Doctors: A Story of Corruption", published in The New York Review of Books (NYRB) magazine, Angell wrote:
...Similar conflicts of interest and biases exist in virtually every field of medicine, particularly those that rely heavily on drugs or devices. It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine .
Hub AI
Marcia Angell AI simulator
(@Marcia Angell_simulator)
Marcia Angell
Marcia Angell (/ˈeɪndʒəl/; born April 20, 1939) is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine. She is currently a Corresponding Member of the Faculty of Global Health and Social Medicine at Harvard Medical School in Boston, Massachusetts.
After completing undergraduate studies in chemistry and mathematics at James Madison University in Harrisonburg, Virginia, Angell spent a year as a Fulbright Scholar studying microbiology in Frankfurt, Germany. After receiving her M.D. from Boston University School of Medicine in 1967, Angell trained in both internal medicine and anatomic pathology and is a board-certified pathologist.
Angell is a frequent contributor to medical journals as well as in the popular media, where she has offered her perspective on topics including medical ethics, health policy, psychiatry, the opioid epidemic, the nature of medical evidence, the interface of medicine and the law, and end-of-life healthcare. Her book, Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case (1996), received critical acclaim. With Stanley Robbins, and later with Vinay Kumar, she co-authored the first three editions of the textbook Basic Pathology. She has written chapters in several books dealing with ethical issues in medicine and healthcare.
Angell is a member of the Association of American Physicians, the Institute of Medicine of the National Academy of Sciences, the Alpha Omega Alpha National Honor Medical Society, and is a Master of the American College of Physicians. She is also a fellow of the Committee for the Scientific Investigation of Claims of the Paranormal and is an outspoken critic of medical quackery and the promotion of alternative medicine.
Angell joined the editorial staff of The New England Journal of Medicine (NEJM) in 1979. She became Executive Editor in 1988, and served as interim Editor-in-Chief from 1999 until June 2000. The NEJM is the oldest continuously published medical journal, and one of the most prestigious; Angell is the first woman to have served as Editor-in-Chief of the journal since it was founded in 1812.
In 1999, Jerome P. Kassirer, M.D. resigned as NEJM's Editor-in-Chief following a dispute with the journal's publisher, the Massachusetts Medical Society, over its plan to use the journal's name to brand and market other sources of healthcare information. Angell agreed to serve as interim Editor-in-Chief until a permanent editor was chosen. She reached an agreement with the Society that the Editor-in-Chief would have authority over usage of the journal's name and logo, and that the journal's name would not be used on other products. She was a finalist for the permanent post of Editor-in-Chief, but withdrew as a candidate explaining that she was retiring to write a book on alternative medicine. Angell retired from the journal in June 2000 and was replaced by Jeffrey Drazen, M.D.
In her 2009 article "Drug Companies & Doctors: A Story of Corruption", published in The New York Review of Books (NYRB) magazine, Angell wrote:
...Similar conflicts of interest and biases exist in virtually every field of medicine, particularly those that rely heavily on drugs or devices. It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine .
Recent media